ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,767.50
0.10%
S&P ASX All Technology
3,137.90
0.55%
Brent Oil
84.85
0.00%
US Dollar vs AUD
1.49566
0.00%
Bitcoin
60,927.96
1.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Bradley Pharmaceuticals (BDY)

  7. Bradley Pharmaceuticals (BDY) News

BDY

Bradley (BDY)

Bradley Pharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:BDY
DateTimeSourceHeadlineSymbolCompany
13/05/200822:18PR Newswire (US)Medimetriks Pharmaceuticals, Inc. Begins OperationsNYSE:BDYBradley Pharmaceuticals
22/02/200810:54PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care IndexNYSE:BDYBradley Pharmaceuticals
22/02/200810:00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Current report filing (8-K)NYSE:BDYBradley Pharmaceuticals
22/02/200810:00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:BDYBradley Pharmaceuticals
22/02/200810:00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:BDYBradley Pharmaceuticals
22/02/200809:55Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:54Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:54Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:53Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:53Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:52Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:52Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:51Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:50Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:47Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:46Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
22/02/200809:02Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Termination of Registration of a Class of Security under Section 12(g) (15-12G/A)NYSE:BDYBradley Pharmaceuticals
15/02/200809:51PR Newswire (US)Standard & Poor's Announces Change to U.S. IndexNYSE:BDYBradley Pharmaceuticals
15/02/200803:36Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
13/02/200808:41Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
07/02/200802:33Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
24/01/200809:20Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended tender offer statement by Issuer (SC TO-I/A)NYSE:BDYBradley Pharmaceuticals
23/01/200806:12Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
18/01/200809:14Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:BDYBradley Pharmaceuticals
18/01/200809:07PR Newswire (US)Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger WitNYSE:BDYBradley Pharmaceuticals
18/01/200804:19Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)NYSE:BDYBradley Pharmaceuticals
18/01/200804:12Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NYSE:BDYBradley Pharmaceuticals
15/12/200701:11Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Current report filing (8-K)NYSE:BDYBradley Pharmaceuticals
14/12/200723:45PR Newswire (US)Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%NYSE:BDYBradley Pharmaceuticals
11/12/200722:01Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NYSE:BDYBradley Pharmaceuticals
 Showing the most relevant articles for your search:NYSE:BDY

Your Recent History

NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
ASX
SUN
Suncorp
ASX
XMM
S&P ASX 300 Metals and M...
ASX
CSL
CSL
ASX
FMG
Fortescue
ASX
ORG
Origin Energy
ASX
AMP
AMP
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
TSLA
Tesla
ASX
XTO
S&P ASX 100
ASX
CBA
Commonwealth Bank Of Aus...
NASDAQ
AMZN
Amazon.com
ASX
RIO
Rio Tinto
ASX
MQG
Macquarie
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved